Listing cost is not one number; it is two groups of money with different behaviour. This page separates them and sets out the five variables that move the total - and why we do not publish a headline figure.
US listing costs come in two groups: fixed costs independent of deal size - audit, US and PRC counsel, restructuring, controls, printing and translation, the exchange initial listing fee; and costs that move with the raise - underwriting, roadshow and investor relations, annual listing fees. We do not publish one headline number, because route, deal size and the number of historical years can move the total by multiples. Pricing follows the route diagnosis, scoped by project and split into those two columns.
| Cost item | Group | When it hits | What drives it |
|---|---|---|---|
| Audit | Fixed | Throughout, heaviest pre-filing | Number of entities, historical years, whether the chart of accounts must be rebuilt |
| US counsel | Fixed | Structure through comment response | Form type, number of comment rounds |
| PRC counsel | Fixed | Restructuring and compliance | Restructuring complexity, FX and sector regulation |
| Structuring | Fixed | Earliest stage | Existing equity structure, offshore entities, VIE arrangements |
| Controls (SOX 404) | Fixed | Starts 12-18 months pre-listing | Process count, system maturity, whether a full year of evidence is missing |
| Printing and translation | Fixed | Filing and roadshow | Document length, revision cycles |
| Initial listing fee | Fixed | Before listing | Exchange and tier, total shares issued |
| Underwriting | Variable | At offering | Deal size and commitment type (firm commitment vs best efforts) |
| Roadshow and IR | Variable | Around the offering | Roadshow scope, years of post-listing IR service |
| Annual listing fee | Variable / recurring | Every year after listing | Exchange tier and shares outstanding |
Further reading: three routes compared · the four-step process · 28 FAQs · 51CFO facts
The same phrase - listing in the US - can differ by multiples, and it all comes from these five. Understanding them beats copying another company's total.
A traditional IPO carries the heaviest workload - prospectus, comment response, roadshow pricing, the full set. A reverse merger drops the offering but adds shell reverse diligence and Super 8-K audits. A SPAC adds S-4 / F-4 and merger-consideration modelling. The three structures are not convertible into one another.
This only moves the variable column: underwriting scales with proceeds and the roadshow scales with it. It is why the question how much does a listing cost has no single answer - raising US$25 million and raising US$200 million are not the same exercise.
A prospectus normally requires several years of financials, and each additional year is a full year of audit and US GAAP conversion. A missing year of workpapers is not an added year - it is a redone year.
The most underestimated variable. With existing IFRS or a mature ERP and a complete chart of accounts, US GAAP conversion compresses to 8-12 weeks. Where the chart of accounts has to be rebuilt and related-party disclosure filled in, it routinely exceeds four months, and the remediation drags controls and the filing schedule with it.
Choice of PCAOB-registered auditor, US filing counsel and underwriter, and whether a bilingual team runs alongside throughout, all land in the cost. Saving here is usually paid back with interest at the comment stage.
These are not money-saving tricks. They are misjudgements that turn into extra cost halfway through.
Because route, deal size and historical years alone can move the total by multiples. Publishing one number is not transparency, it is a misleading number. The workable sequence: the 30-minute route diagnosis settles route and scope, then pricing is scoped by project and split into fixed and variable columns - so you can see which part can be compressed and which cannot.
It scales with proceeds, normally taken as a percentage deducted from offering proceeds, with the percentage depending on deal size, commitment type (firm commitment versus best efforts) and market conditions at pricing. We do not publish a range - it varies too much case by case to be useful on a page - and the actual terms are set by the underwriter before the offering and written into the underwriting agreement.
Recurring costs include the annual audit, 10-K / 20-F and 10-Q preparation, annual SOX 404 testing and auditor attestation once the emerging growth company exemption is lost, investor relations and disclosure services, the exchange annual fee, and D&O insurance. These recur every year and belong in the budget before listing, not discovered afterwards.
Audit remediation and controls. It does not sit in a visible line of the offering documents, but it runs through the whole process and gets more expensive the lower the starting point: a missing year of workpapers means redoing the year, and controls that were performed but not documented were not performed. These two decide your timeline and whether comment rounds stall you.
The quote holds for the scope signed - if scope does not change, price does not change. It moves in only two cases, both confirmed in writing in advance: the scope itself changes (a third historical year, an added offshore entity to restructure), or remediation appears during the audit that could not be foreseen at signing. In both cases you get a written change note and the corresponding price before work starts.
一次 30 分钟的上市路径诊断：我们评估你适合的上市路径、时间表与团队缺口，并给出下一步建议。免费，且完全保密。